Recent mouse and rat methods for the study of experimental oral candidiasis

Virulence

Volumn 4, Issue 5, 2013, Pages 391-399

  Costa, Anna C B P ^a,b   Pereira, Cristiane A ^a   Junqueira, Juliana C ^a   Jorge, Antonio O C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Candida albicans; Murine model; Oral candidiasis; Oral cavity

Indexed keywords

AMPHOTERICIN B; DEXAMETHASONE; FARNESOL; FLUCONAZOLE; LACTOFERRIN; TETRACYCLINE;

ARTICLE; BACTERIAL COLONIZATION; CANDIDA ALBICANS; COLONY FORMING UNIT; CONFOCAL LASER MICROSCOPY; DISEASE SEVERITY; EPITHELIUM HYPERPLASIA; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; MUSCLE CELL; NONHUMAN; PHOTODYNAMIC THERAPY; RISK FACTOR; SPRAGUE DAWLEY RAT; THRUSH; TONGUE; WISTAR RAT;

EID: 84880078584     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.25199     Document Type: Article

References (71)

1. Gugnani HC, Becker K, Fegeler W, Basu S, Chattopadhya D, Baveja U, et al. Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses 2003; 46:299-306. PMID:12950898. http://dx.doi.org/10.1046/j.1439-0507.2003.00896.x
2. Pomarico L, Cerqueira DF, de Araujo Soares RM, de Souza IP, de Araujo Castro GF, Socransky S, et al. Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108:203-10. PMID:19615660. http://dx.doi. org/10.1016/j.tripleo.2009.05.008
3. Delgado ACD, de Jesus Pedro R, Aoki FH, Resende MR, Trabasso P, Colombo AL, et al. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization. Clin Microbiol Infect 2009; 15:364-71. PMID:19431223. http://dx.doi. org/10.1111/j.1469-0691.2009.02707.x
4. Jainkittivong A, Lin AL, Johnson DA, Langlais RP, Yeh CK. Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients. Oral Dis 2009; 15:229-34. PMID:19207880. http://dx.doi. org/10.1111/j.1601-0825.2009.01514.x
5. Luque AG, Biasoli MS, Tosello ME, Binolfi A, Lupo S, Magaró HM. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina. Mycoses 2009; 52:53-9. PMID:18498298. http:// dx.doi.org/10.1111/j.1439-0507.2008.01542.x
6. Ribeiro PM, Bacal F, Koga-Ito CY, Junqueira JC, Jorge AOC. Presence of Candida spp. in the oral cavity of heart transplantation patients. J Appl Oral Sci 2011; 19:6-10. PMID:21437462. http://dx.doi.org/10.1590/S1678-77572011000100003
7. Junqueira JC, Vilela SFG, Rossoni RD, Barbosa JO, Costa ACBP, Rasteiro VMC, et al. Oral colonization by yeasts in HIV-positive patients in Brazil. Rev Inst Med Trop Sao Paulo 2012; 54:17-24. PMID:22370749. http://dx.doi.org/10.1590/S0036-46652012000100004
8. Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48:365-77. PMID:16262871. http:// dx.doi.org/10.1111/j.1439-0507.2005.01165.x
9. Mishra NN, Prasad T, Sharma N, Payasi A, Prasad R, Gupta DK, et al. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. Acta Microbiol Immunol Hung 2007; 54:201-35. PMID:17896473. http://dx.doi.org/10.1556/ AMicr.54.2007.3.1
10. Junqueira JC, Fuchs BB, Muhammed M, Coleman JJ, Suleiman JM, Vilela SF, et al. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. BMC Microbiol 2011; 11:247. PMID:22053894. http://dx.doi.org/10.1186/1471-2180-11-247
11. Silva S, Henriques M, Oliveira R, Williams D, Azeredo J. In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol 2010; 61:534-40. PMID:20401483. http://dx.doi.org/10.1007/s00284-010-9649-7
12. Seneviratne CJ, Jin L, Samaranayake LP. Biofilm life-style of Candida: a mini review. Oral Dis 2008; 14:582-90. PMID:19076549. http://dx.doi.org/10.1111/ j.1601-0825.2007.01424.x
13. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol 2009; 35:340-55. PMID:19863383. http://dx.doi.org/10.3109/10408410903241436
14. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46:1773-1780. PMID:12019089. http://dx.doi.org/10.1128/AAC.46.6.1773-1780.2002
15. Rautemaa R, Ramage G. Oral candidosis--clinical challenges of a biofilm disease. Crit Rev Microbiol 2011; 37:328-36. PMID:21777047. http://dx.doi.org/10.3109/1040841X.2011.585606
16. Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol 2011; 3:5771. PMID:21547018. http://dx.doi.org/10.3402/jom. v3i0.5771
17. Campisi G, Panzarella V, Matranga D, Calvino F, Pizzo G, Lo Muzio L, et al. Risk factors of oral candidosis: a twofold approach of study by fuzzy logic and traditional statistic. Arch Oral Biol 2008; 53:388-97. PMID:18191810. http://dx.doi.org/10.1016/j.archoralbio.2007.11.009
18. Komiyama EY, Ribeiro PM, Junqueira JC, Koga-Ito CY, Jorge AOC. Prevalence of yeasts in the oral cavity of children treated with inhaled corticosteroids. Braz Oral Res 2004; 18:197-201. PMID:15619871. http:// dx.doi.org/10.1590/S1806-83242004000300004
19. Fukushima C, Matsuse H, Saeki S, Kawano T, Machida I, Kondo Y, et al. Salivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroid. J Asthma 2005; 42:601-4. PMID:16169797. http:// dx.doi.org/10.1080/02770900500216259
20. Radfar L, Shea Y, Fischer SH, Sankar V, Leakan RA, Baum BJ, et al. Fungal load and candidiasis in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96:283-7. PMID:12973284. http://dx.doi.org/10.1016/S1079-2104(03)00224-5
21. Ohman SC, Jontell M. Treatment of angular cheilitis. The significance of microbial analysis, antimicrobial treatment, and interfering factors. Acta Odontol Scand 1988; 46:267-72. PMID:3063051. http://dx.doi. org/10.3109/00016358809004776
22. Weerasuriya N, Snape J. Oesophageal candidiasis in elderly patients: risk factors, prevention and management. Drugs Aging 2008; 25:119-30. PMID:18257599. http://dx.doi.org/10.2165/00002512-200825020-00004
23. Soysa NS, Samaranayake LP, Ellepola AN. Diabetes mellitus as a contributory factor in oral candidosis. Diabet Med 2006; 23:455-9. PMID:16681553. http://dx.doi.org/10.1111/j.1464-5491.2005.01701.x
24. Samaranayake LP. Nutritional factors and oral candidosis. J Oral Pathol 1986; 15:61-5. PMID:3083063. http://dx.doi.org/10.1111/j.1600-0714.1986. tb00578.x
25. Soysa NS, Samaranayake LP, Ellepola AN. Antimicrobials as a contributory factor in oral candidosis--a brief overview. Oral Dis 2008; 14:138-43. PMID:18302673. http://dx.doi.org/10.1111/j.1601-0825.2006.01357.x
26. Egusa H, Soysa NS, Ellepola AN, Yatani H, Samaranayake LP. Oral candidosis in HIV-infected patients. Curr HIV Res 2008; 6:485-99. PMID:18991614. http:// dx.doi.org/10.2174/157016208786501445
27. Hamza OJ, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol 2008; 8:135. PMID:18694525. http://dx.doi. org/10.1186/1471-2180-8-135
28. Badiee P, Alborzi A, Davarpanah MA, Shakiba E. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch Iran Med 2010; 13:282-7. PMID:20597560
29. Samaranayake LP, Keung Leung W, Jin L. Oral mucosal fungal infections. Periodontol 2000 2009; 49:39-59. PMID:19152525. http://dx.doi.org/10.1111/j.1600-0757.2008.00291.x
30. Farah CS, Lynch N, McCullough MJ. Oral fungal infections: an update for the general practitioner. Aust Dent J 2010; 55(Suppl 1):48-54. PMID:20553244. http://dx.doi.org/10.1111/j.1834-7819.2010.01198.x
31. Williams DW, Kuriyama T, Silva S, Malic S, Lewis MA. Candida biofilms and oral candidosis: treatment and prevention. Periodontol 2000 2011; 55:250-65. PMID:21134239. http://dx.doi.org/10.1111/j.1600-0757.2009.00338.x
32. Gendreau L, Loewy ZG. Epidemiology and etiology of denture stomatitis. J Prosthodont 2011; 20:251-60. PMID:21463383. http://dx.doi.org/10.1111/j.1532-849X.2011.00698.x
33. Martin R, Wächtler B, Schaller M, Wilson D, Hube B. Host-pathogen interactions and virulence-associated genes during Candida albicans oral infections. Int J Med Microbiol 2011; 301:417-22. PMID:21555244. http://dx.doi.org/10.1016/j.ijmm.2011.04.009
34. Gow NA, Hube B. Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol 2012; 15:406-12. PMID:22609181. http://dx.doi.org/10.1016/j.mib.2012.04.005
35. Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. Clin Microbiol Rev 2001; 14:398-429. PMID:11292645. http://dx.doi. org/10.1128/CMR.14.2.398-429.2001
36. Junqueira JC. Models hosts for the study of oral candidiasis. Adv Exp Med Biol 2012; 710:95-105. PMID:22127889. http://dx.doi.org/10.1007/978-1-4419-5638-5_10
37. Takakura N, Sato Y, Ishibashi H, Oshima H, Uchida K, Yamaguchi H, et al. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol 2003; 47:321-6. PMID:12825893
38. Totti MAG, Santos EB, Almeida OP, Jorge AOC. Implantation and permanency of Candida albicans in the oral cavity of normal sialodenectomized mice after a single inoculation of yeast. Braz J Oral Sci 2002; 1:133-6
39. Junqueira JC, Colombo CED, Martins JdaS, Koga Ito CY, Carvalho YR, Jorge AOC. Experimental candidosis and recovery of Candida albicans from the oral cavity of ovariectomized rats. Microbiol Immunol 2005; 49:199-207. PMID:15781993
40. Ishibashi H, Hisajima T, Hu W, Yamaguchi H, Nishiyama Y, Abe S. A murine model of esophageal candidiasis with local characteristic symptoms. Microbiol Immunol 2007; 51:501-6. PMID:17579259
41. Taguchi Y, Takizawa T, Ishibashi H, Sagawa T, Arai R, Inoue S, et al. Therapeutic effects on murine oral candidiasis by oral administration of cassia (Cinnamomum cassia) preparation. Nihon Ishinkin Gakkai Zasshi 2010; 51:13-21. PMID:20185867. http://dx.doi. org/10.3314/jjmm.51.13
42. Martins JS, Junqueira JC, Faria RL, Santiago NF, Rossoni RD, Colombo CED, et al. Antimicrobial photodynamic therapy in rat experimental candidiasis: evaluation of pathogenicity factors of Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111:71-7. PMID:21176823. http://dx.doi. org/10.1016/j.tripleo.2010.08.012
43. Costa AC, Campos Rasteiro VM, da Silva Hashimoto ES, Araújo CF, Pereira CA, Junqueira JC, et al. Effect of erythrosine-and LED-mediated photodynamic therapy on buccal candidiasis infection of immunosuppressed mice and Candida albicans adherence to buccal epithelial cells. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114:67-74. PMID:22727094. http://dx.doi. org/10.1016/j.oooo.2012.02.002
44. Miranda TT, Vianna CR, Rodrigues L, Monteiro AS, Rosa CA, Corrêa A Jr. Diversity and frequency of yeasts from the dorsum of the tongue and necrotic root canals associated with primary apical periodontitis. Int Endod J 2009; 42:839-44. PMID:19712195. http://dx.doi. org/10.1111/j.1365-2591.2009.01601.x
45. Allen CM. Animal models of oral candidiasis. A review. Oral Surg Oral Med Oral Pathol 1994; 78:216-21. PMID:7936592. http://dx.doi.org/10.1016/0030-4220(94)90150-3
46. Naglik JR, Fidel PL Jr., Odds FC. Animal models of mucosal Candida infection. FEMS Microbiol Lett 2008; 283:129-39. PMID:18422625. http://dx.doi. org/10.1111/j.1574-6968.2008.01160.x
47. Jorge AO, Totti MA, de Almeida OP, Scully C. Oral candidiasis established in the sialoadenectomised rat. J Oral Pathol Med 1993; 22:54-6. PMID:8445543. http://dx.doi.org/10.1111/j.1600-0714.1993. tb00042.x
48. Liu B, Dion MR, Jurasic MM, Gibson G, Jones JA. Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114:52-60. PMID:22727092. http://dx.doi.org/10.1016/j. oooo.2011.11.014
49. Desoutter A, Soudain-Pineau M, Munsch F, Mauprivez C, Dufour T, Coeuriot JL. Xerostomia and medication: a cross-sectional study in long-term geriatric wards. J Nutr Health Aging 2012; 16:575-9. PMID:22660000. http://dx.doi.org/10.1007/s12603-012-0007-2
50. Green CB, Marretta SM, Cheng G, Faddoul FF, Ehrhart EJ, Hoyer LL. RT-PCR analysis of Candida albicans ALS gene expression in a hyposalivatory rat model of oral candidiasis and in HIV-positive human patients. Med Mycol 2006; 44:103-11. PMID:16519012. http://dx.doi.org/10.1080/13693780500086527
51. Fisker AV, Schiøtt CR, Philipsen HP. Long-term oral candidosis in rats. Acta Pathol Microbiol Immunol Scand B 1982; 90:221-7. PMID:6214922
52. Junqueira JC, Martins JdaS, Faria RL, Colombo CED, Jorge AOC. Photodynamic therapy for the treatment of buccal candidiasis in rats. Lasers Med Sci 2009; 24:877-84. PMID:19408038. http://dx.doi. org/10.1007/s10103-009-0673-4
53. Chami N, Chami F, Bennis S, Trouillas J, Remmal A. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. Braz J Infect Dis 2004; 8:217-26. PMID:15476054. http://dx.doi. org/10.1590/S1413-86702004000300005
54. Núñez MJ, Novío S, Suárez JA, Balboa J, Freire-Garabal M. Effects of psychological stress and fluoxetine on development of oral candidiasis in rats. Clin Vaccine Immunol 2010; 17:668-73. PMID:20130126. http://dx.doi.org/10.1128/CVI.00380-09
55. Johnson CC, Yu A, Lee H, Fidel PL Jr., Noverr MC. Development of a contemporary animal model of Candida albicans-associated denture stomatitis using a novel intraoral denture system. Infect Immun 2012; 80:1736-43. PMID:22392931. http://dx.doi. org/10.1128/IAI.00019-12
56. Nett JE, Marchillo K, Spiegel CA, Andes DR. Development and validation of an in vivo Candida albicans biofilm denture model. Infect Immun 2010; 78:3650-9. PMID:20605982. http://dx.doi. org/10.1128/IAI.00480-10
57. Farah CS, Elahi S, Drysdale K, Pang G, Gotjamanos T, Seymour GJ, et al. Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis. Infect Immun 2002; 70:724-31. PMID:11796605. http:// dx.doi.org/10.1128/IAI.70.2.724-731.2002
58. de Repentigny L. Animal models in the analysis of Candida host-pathogen interactions. Curr Opin Microbiol 2004; 7:324-9. PMID:15288620. http:// dx.doi.org/10.1016/j.mib.2004.06.001
59. Totti MAG, dos Santos EB, de Almeida OP, Koga-Ito CY, Jorge AOC. Oral candidosis by Candida albicans in normal and xerostomic mice. Braz Oral Res 2004; 18:202-7. PMID:15619872. http://dx.doi. org/10.1590/S1806-83242004000300005
60. Rahman D, Mistry M, Thavaraj S, Challacombe SJ, Naglik JR. Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes Infect 2007; 9:615-22. PMID:17383212. http://dx.doi. org/10.1016/j.micinf.2007.01.012
61. Solis NV, Filler SG. Mouse model of oropharyngeal candidiasis. Nat Protoc 2012; 7:637-42. PMID:22402633. http://dx.doi.org/10.1038/nprot.2012.011
62. Takakura N, Wakabayashi H, Ishibashi H, Yamauchi K, Teraguchi S, Tamura Y, et al. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 2004; 53:495-500. PMID:15150327. http://dx.doi. org/10.1099/jmm.0.05505-0
63. Kamagata-Kiyoura Y, Abe S, Yamaguchi H, Nitta T. Protective effects of human saliva on experimental murine oral candidiasis. J Infect Chemother 2004; 10:253-5. PMID:15365870. http://dx.doi. org/10.1007/s10156-004-0330-6
64. Hisajima T, Maruyama N, Tanabe Y, Ishibashi H, Yamada T, Makimura K, et al. Protective effects of farnesol against oral candidiasis in mice. Microbiol Immunol 2008; 52:327-33. PMID:18667031. http:// dx.doi.org/10.1111/j.1348-0421.2008.00044.x
65. Yanagi M, Hisajima T, Ishibashi H, Amemiya A, Abe S, Watanabe M. Oral candidiasis deteriorated by local application of a glucocorticoid-containing film in a mouse model. Biol Pharm Bull 2008; 31:278-83. PMID:18239287. http://dx.doi.org/10.1248/ bpb.31.278
66. Mima EGO, Pavarina AC, Dovigo LN, Vergani CE, Costa CAS, Kurachi C, et al. Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109:392-401. PMID:20060338. http://dx.doi.org/10.1016/j.tripleo.2009.10.006
67. Ninomiya K, Maruyama N, Inoue S, Ishibashi H, Takizawa T, Oshima H, et al. The essential oil of Melaleuca alternifolia (tea tree oil) and its main component, terpinen-4-ol protect mice from experimental oral candidiasis. Biol Pharm Bull 2012; 35:861-5. PMID:22687476. http://dx.doi.org/10.1248/ bpb.35.861
68. Hayama K, Ishibashi H, Ishijima SA, Niimi K, Tansho S, Ono Y, et al. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model. FEMS Microbiol Lett 2012; 328:130-7. PMID:22211961. http://dx.doi. org/10.1111/j.1574-6968.2011.02490.x
69. Teichert MC, Jones JW, Usacheva MN, Biel MA. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93:155-60. PMID:11862203. http://dx.doi.org/10.1067/moe.2002.120051
70. Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J. Characterization of mucosal Candida albicans biofilms. PLoS One 2009; 4:e7967. PMID:19956771. http://dx.doi.org/10.1371/journal. pone.0007967
71. Mosci P, Pericolini E, Gabrielli E, Kenno S, Perito S, Bistoni F, et al. A novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice. Virulence 2013; 4:250-4. PMID:23334179. http:// dx.doi.org/10.4161/viru.23529